Countries South Korea
Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...
May 13, 2026 | News
ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...
May 12, 2026 | News
RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, ...
May 11, 2026 | News
Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Kore...
May 08, 2026 | News
Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in ...
May 06, 2026 | News
Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and deve...
April 29, 2026 | News
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...
April 24, 2026 | News
SynbioTech announced that its Lactiplantibacillus plantarum FS4722 (L. plantarum FS4722), a probiotic strain isolated from traditional Chine...
April 23, 2026 | News
ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first...
April 23, 2026 | News
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG B...
April 07, 2026 | News
Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishe...
April 02, 2026 | News
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule...
March 31, 2026 | News
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to ...
March 31, 2026 | News
Most Read
Bio Jobs
News
Editor Picks